Spectacles filter to help migraine sufferers

Article

A new product, MigraLens, designed to filter red and blue light and help migraine sufferers is now available in the UK in a range of branded plano eyewear including fit-overs for presciption glasses.

A new product, MigraLens, designed to filter red and blue light and help migraine sufferers is now available in the UK in a range of branded plano eyewear including fit-overs for presciption glasses.

The flicker and glare absorbing filter has been trialled by its developer, Mediview, with members of the Macular Disease Society and now, Migraine Action too. Lee Tomkins, Director of Migraine Action, a UK charity that offers advice and support to migraine sufferers commented: “Our members have found that MigraLens is able to minimise the problems caused by flicker and glare and we are confident that it will become a useful new addition to existing migraine treatments available to light sensitive sufferers.”

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.